(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks rose on Thursday after consumer spending recorded its largest increase in nearly six years and the U.S. Supreme Court backed Obamacare, boosting healthcare stocks. The Dow Jones industrial average was up 0.18 percent at 17,998.4, the S&P 500 was up 0.25 percent at 2,113.76 and the Nasdaq Composite was up 0.29 percent at 5,137.45
** CLEVELAND BIOLABS INC, $6.89, +143.46 pct
The drug developer signed a private placement agreement with David Davidovich, a venture capital investor, for sale of 6.4 million common shares at $3.87/share for $25 million.
** MAGNUM HUNTER RESOURCES CORP, $1.965, +12.29 pct
The oil and natural gas producer said it expected to raise $600-$700 million by selling its 45.53 percent stake in its natural gas gathering subsidiary, Eureka Hunter Holdings.
** IAC/INTERACTIVECORP, $81.1, +4.97 pct
The media company, controlled by media mogul Barry Diller, said it planned to list its dating business, which includes dating website Match.com and mobile dating app Tinder.
** UNITEDHEALTH GROUP, $121.99, +2.37 pct
** CENTENE CORP, $81.24, +3.73 pct
** HCA HOLDINGS, $90.39, +8.42 pct
** TENET HEALTHCARE CORP, $55.9, +11.62 pct
U.S. hospital shares surged, with several hitting all-time highs, and other healthcare names rallied on Thursday after the U.S. Supreme Court upheld tax subsidies key to President Barack Obama’s signature healthcare law.
** VENAXIS INC, $0.482, -13.31 pct
The diagnostic test maker said FDA reviewers needed more clinical data supporting revised intended use for blood testing system, APPY1. On Jan. 29, the agency did not find APPY1 to be “substantially equivalent” to standard of care.
** REAL GOODS SOLAR INC, $4.73, +29.95 pct
The solar company converted subordinated debt to class A shares and will convert outstanding principal of $3.15 mln and accrued interest of $1.09 million to 1.28 million Class A stock at Tuesday’s closing price of $3.29.
** WORLD ACCEPTANCE CORP, $67.03, -19.07 pct
The provider of loans to individuals’ shares fell after brokerage FBR cut to “market perform” from “outperform, following the company’s announcement on Wednesday it entered into ninth amendment to amended and restated revolving credit agreement.
** BROADWIND ENERGY INC, $4.41, +11.08 pct
The energy infrastructure provider said that it got $50 million in new tower orders from a U.S. wind turbine maker.
** CREE INC, $27.2201, -10.93 pct
The company, which makes lighting and semiconductor products, said it would reduce manufacturing capacity at its light-emitting diode factory, as it struggles with a decline in prices, and take an $85 million restructuring charge.
** MARTHA STEWART LIVING OMNIMEDIA INC, $6.5, +5.52 pct
** SEQUENTIAL BRANDS GROUP INC, $15.69, -3.56 pct
The media company’s shares rose after New York Post reports its deal to be acquired by Sequential is in flux after Sequential CEO leaked story before it was finalized.
Post reports Martha Stewart now being stalked by at least five bidders this week.
** AQUINOX PHARMACEUTICALS INC, $7.5999, -3.55 pct
The pain drug developer said its drug for bladder pain did not have statistically significant effect on patients in mid-stage study, compared with placebo.
** ELI LILLY AND CO, $86.46, +5.11 pct
The drugmaker said it won patent case in Court of Appeal in London over its blockbuster lung cancer drug Alimta, dealing a blow to generic challenger Actavis, which has since changed its name to Allergan Plc.
** TRANSUNION, $24.62, +9.42 pct
Shares of the credit bureau rose as much as 10 percent in their debut, valuing the company at about $4.4 billion.
** FITBIT INC, $36.87, +2.39 pct
Brokerage Leerink Partners LLC starts coverage of the wearable fitness-tracking device maker with “outperform” rating and a $44 price target.
“We believe higher sales growth will be driven in part by a robust corporate wellness market in which Fitbit is already the brand leader.”
** MERRIMACK PHARMACEUTICALS INC, $12.74, +7.06 pct
The cancer drug developer says FDA grants priority review status to experimental cancer drug MM-398 and sets decision date for Oct. 24.
** BARNES & NOBLE INC, $25.5, -3.15 pct
U.S.’s largest bookstore chain reported a fall in sales for the fourth consecutive quarter as demand for the company’s Nook tablets continued to fall and customers stayed away from its brick-and-mortar bookstores.
** WINNEBAGO INDUSTRIES INC, $22.21, +7.29 pct
The largest U.S. motorhome maker reported better-than-expected quarterly revenue as it shipped more vehicles. (Compiled by Anya George Tharakan in Bengaluru; Editing by Sriraj Kalluvila)